Concepedia

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study

Phil Ambery, Victoria E R Parker, Michael Stümvoll, Maximilian Posch, Tim Heise, Lan-Feng Tsai, Darren Robertson, Meena Jain, Marcella Petrone, Cristina M. Rondinone,

The Lancet · 2018 · 295 citations · 43 references

DOI

Concepts

References

43

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

The Lancet · 1998 · 20.1K citations

, , +13

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

New England Journal of Medicine · 2002 · 19K citations · Full text

, , +1

Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery

Lars Sjöström, Anna‐Karin Lindroos, Markku Peltonen et al. · New England Journal of Medicine · 2004 · 4.5K citations · Full text

, , +14

Abdominal Visceral and Subcutaneous Adipose Tissue Compartments

Caroline S. Fox, Joseph M. Massaro, Udo Hoffmann et al. · Circulation · 2007 · 2.9K citations · Full text

, , +15

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

Philip R. Schauer, Deepak L. Bhatt, John P. Kirwan et al. · New England Journal of Medicine · 2017 · 2.9K citations · Full text

, , +16